Crohn's Disease: Risankizumab as Induction- and Maintenance Therapy

被引：0
|
作者：
Franke, Katharina
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2022年 / 147卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1085 / 1085
页数：1
相关论文
共 50 条
  • [41] Induction and Maintenance Adalimumab Therapy for the Treatment of Moderate to Severe Crohn's Disease in Children
    Hyams, Jeffrey S.
    Griffiths, Anne M.
    Markowitz, James
    Baldassano, Robert
    Faubion, William A.
    Colletti, Richard B.
    Dubinsky, Maria
    Kierkus, Jaroslaw
    Wang, Yaqin
    Huang, Bidan
    Bittle, Barry
    Marshall, Michael
    Lazar, Andreas
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S90 - S90
  • [42] Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's Disease
    Dubinsky, Marla
    Ma, Christopher
    Griffith, Jenny
    Crowell, Marjorie
    Neimark, Ezequiel
    Kligys, Kristina
    O'Connell, Tom
    [J]. ADVANCES IN THERAPY, 2023, 40 (09) : 3896 - 3911
  • [43] EFFICACY AND SAFETY OF OPEN-LABEL MAINTENANCE THERAPY WITH SUBCUTANEOUS RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE
    Feagan, Brian G.
    Panes, Julian
    Ferrante, Marc
    Kaser, Arthur
    D'Haens, Geert R.
    Sandborn, William J.
    Louis, Edouard
    Neurath, Markus
    Franchimont, Denis
    Dewit, Olivier
    Seidler, Ursula
    Kim, Kyung-Jo
    Selinger, Christian
    Padula, Steven J.
    Herichova, Ivona
    Robinson, Anne M.
    Wallace, Kori
    Zhao, Jun
    Soaita, Adina
    Visvanathan, Sudha
    Hall, David
    Bocher, Wulf O.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1310 - S1310
  • [44] Effectiveness of risankizumab induction and maintenance therapy for refractory Crohn's disease: a real-world experience from a preapproval access programme and early access to medicines scheme
    Zare, Benjamin
    Gros, Beatriz
    Lal, Natasha
    Dawson, Patrick
    Sharma, Esha
    Dart, Robin J.
    Lim, Samuel
    Ray, Shuvra
    Anderson, Simon H. C.
    Mawdsley, Joel
    Irving, Peter M.
    Lees, Charlie W.
    Samaan, Mark A.
    [J]. FRONTLINE GASTROENTEROLOGY, 2024,
  • [45] Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn’s Disease
    Marla Dubinsky
    Christopher Ma
    Jenny Griffith
    Marjorie Crowell
    Ezequiel Neimark
    Kristina Kligys
    Tom O’Connell
    [J]. Advances in Therapy, 2023, 40 : 3896 - 3911
  • [46] Risankizumab Results in Improvements in Disease Activity Scores in Patients With Crohn's Disease: Post-Hoc Analysis of the Phase 3 Induction and Maintenance Studies
    Loftus, Edward V.
    Ferrante, Marc
    Colombel, Jean-Frederic
    Kligys, Kristina
    Van Haaren, Stijn
    Song, Alexandra
    Neimark, Ezequiel
    Zambrano, Javier
    Liao, Xiaomei
    Dubinsky, Marla
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S529 - S529
  • [47] Effectiveness and Safety of Risankizumab Induction Therapy in Crohn's Disease: Prospective Real-World Experience in a Large Tertiary Center
    Zinger, Adar
    Choi, David K.
    Choi, Natalie K.
    Garcia, Nicole M.
    Cohen, Russell D.
    Dalal, Sushila
    Cleveland, Noa Krugliak
    Rubin, David T.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S834 - S834
  • [48] RISANKIZUMAB DOSE ESCALATION IN PATIENTS WITH CROHN'S DISEASE
    Nichols, Patrick
    Kozlicki, Miranda
    Fann, Jessica
    Zuckerman, Autumn
    Dalal, Robin
    [J]. INFLAMMATORY BOWEL DISEASES, 2024, 30 : S88 - S89
  • [49] Risankizumab Is Effective for The Management of Crohn's Disease of the Pouch
    Kayal, Maia
    Spencer, Elizabeth A.
    Smyth, Matthew
    Raffals, Laura
    Qazi, Taha
    Deepak, Parakkal
    Beniwal-Patel, Poonam
    Chang, Shannon
    Higgins, Peter
    Cross, Raymond K.
    Anderson, Chelsea
    Long, Millie
    Herfarth, Hans H.
    Dubinsky, Marla C.
    Barnes, Edward L.
    [J]. INFLAMMATORY BOWEL DISEASES, 2024,
  • [50] Tolerability of Ustekinumab in Induction and Maintenance for the Treatment of Crohn's Disease
    Loftus, Edward V., Jr.
    Sattin, Bernie
    Jacobstein, Douglas
    Gasink, Christopher
    Sloan, Sheldon
    Feagan, Brian G.
    Colombel, Jean-Frederic
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S364 - S364
12345